Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis.
- DOI
- 10.1111/ejh.70117
- Published
- 2026 May
- Container
- European journal of haematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/ejh.70117,
title = {Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis.},
author = {Djambas Khayat C and Dubey L and Inati A and Lissitchkov T and Novik D and Peteva E and Sidonio RF Jr and Taher AT and Vilchevska KV and Vdovin V and Boban A},
year = {2026},
journal = {European journal of haematology},
doi = {10.1111/ejh.70117},
url = {https://doi.org/10.1111/ejh.70117}
}RIS
TY - JOUR TI - Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis. AU - Djambas Khayat C AU - Dubey L AU - Inati A AU - Lissitchkov T AU - Novik D AU - Peteva E AU - Sidonio RF Jr AU - Taher AT AU - Vilchevska KV AU - Vdovin V AU - Boban A PY - 2026 JO - European journal of haematology DO - 10.1111/ejh.70117 UR - https://doi.org/10.1111/ejh.70117 ER -
APA
C, D. K., L, D., A, I., T, L., D, N., E, P., Jr, S. R., AT, T., KV, V., V, V., & A, B. (2026). Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis.. European journal of haematology. https://doi.org/10.1111/ejh.70117
Source records
- pubmed · retrieved 2026-09-26T16:10:17.853Z